DMAC
DiaMedica Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$7.28
+0.04 ▲ +0.55%
🌙 3월 13일 4:20 PM ET (한국 3/14 05:20)
$7.28
+0.00 +0.00%
| Index | RUT | P/E | - | EPS (ttm) | -0.72 | Insider Own | 52.12% | Shs Outstand | 0.05B | Perf Week | -5.58% |
| Market Cap | 0.38B | Forward P/E | - | EPS next Y | -10.53% | Insider Trans | 4.07% | Shs Float | 0.02B | Perf Month | -12.29% |
| Enterprise Value | 0.32B | PEG | - | EPS next Q | -0.18 | Inst Own | 23.39% | Short Float | 16.63% | Perf Quarter | -22.14% |
| Income | -0.03B | P/S | - | EPS this Y | -14% | Inst Trans | -12.56% | Short Ratio | 16.56 | Perf Half Y | - |
| Sales | 0.00B | P/B | 7.34 | EPS next 5Y | -13.62% | ROA | -58.27% | Short Interest | 4.15M | Perf YTD | -8.54% |
| Book/sh | 0.99 | P/C | 6.85 | EPS past 3/5Y | 2.58% 7.39% | ROE | -64.12% | 52W High | -30.13% ($10.42) | Perf Year | 28.4% |
| Cash/sh | 1.06 | P/FCF | - | Sales past 3/5Y | - | ROIC | -61.66% | 52W Low | 128.21% ($3.19) | Perf 3Y | 318.39% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -29.73% | Gross Margin | - | Volatility(W/M) | 6.52% 5.55% | Perf 5Y | -25.26% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.47 | Perf 10Y | 227.93% |
| Dividend Ex-Date | - | Quick Ratio | 10.67 | EPS Q/Q | -18.4% | Profit Margin | - | RSI (14) | 35.95 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 10.67 | Sales Q/Q | - | SMA20 | -9.48% ($8.04) | Beta | 1.12 | Target Price | $15.5 |
| Payout | - | Debt/Eq | 0.01 | Earnings | 11000000 | SMA50 | -10.78% ($8.16) | Rel Volume | 0.96 | Prev Close | $7.24 |
| Employees | 28 | LT Debt/Eq | 0 | EPS/Sales Surpr. | -6.25% - | SMA200 | 10.63% ($6.58) | Avg Volume(3M) | 0.25M | Price | $7.28 |
| IPO | 2008/1/4 | Option/Short | Yes/Yes | Trades | 4164 | Volume | 240,634 | Change | 0.55% |
뉴스 로딩 중...